Projects

National

• Effects of mesenchymal stem cells and HMGB1 inhibitor on cardiovascular system after experimentally induced myocardial infarction in hypertension and diabetes mellitus
  Program: SRDA
  Duration: 1. 7. 2023 – 30. 6. 2027